RSS feedabbott
’CDS report: Mixed US data weigh on market
Gavan Nolan of Markit wrote this CDS report
The European credit markets took a turn for the worse this afternoon following another session of mixed US economic data. The Markit iTraxx Europe was trading around 88bp (3.5bp,
Vaccines give a boost to pharma M&A
A recent flurry of deals in the pharmaceutical sector highlights what savvy investors have known for some time — vaccines are the new M&A targets.
The Wall Street Journal notes on Monday that the recent health scares over global pandemics and the growing involvement of governments in purchasing vaccines en masse have become key driving forces in the thriving world of pharma M&A.
Abbott reinforces consolidation trend
Abbott, the US pharmaceutical company, reinforced the growing trend of consolidation in the global pharma sector with a €4.5bn ($6.5bn) agreed purchase of the drugs arm of Belgium’s Solvay Group on Monday.
GE in advanced talks for Abbott’s diagnostics unit
General Electric is in advanced talks to buy the medical diagnostics unit of Abbott Laboratories for up to $8bn in what could be GE’s second multi-billion dollar acquisition in less than a week. The move,